190 related articles for article (PubMed ID: 22471905)
1. Transport and pharmacodynamics of albitiazolium, an antimalarial drug candidate.
Wein S; Maynadier M; Bordat Y; Perez J; Maheshwari S; Bette-Bobillo P; Tran Van Ba C; Penarete-Vargas D; Fraisse L; Cerdan R; Vial H
Br J Pharmacol; 2012 Aug; 166(8):2263-76. PubMed ID: 22471905
[TBL] [Abstract][Full Text] [Related]
2. A chemical proteomics approach for the search of pharmacological targets of the antimalarial clinical candidate albitiazolium in Plasmodium falciparum using photocrosslinking and click chemistry.
Penarete-Vargas DM; Boisson A; Urbach S; Chantelauze H; Peyrottes S; Fraisse L; Vial HJ
PLoS One; 2014; 9(12):e113918. PubMed ID: 25470252
[TBL] [Abstract][Full Text] [Related]
3. New insight into the mechanism of accumulation and intraerythrocytic compartmentation of albitiazolium, a new type of antimalarial.
Wein S; Tran Van Ba C; Maynadier M; Bordat Y; Perez J; Peyrottes S; Fraisse L; Vial HJ
Antimicrob Agents Chemother; 2014 Sep; 58(9):5519-27. PubMed ID: 25001307
[TBL] [Abstract][Full Text] [Related]
4. High Accumulation and
Wein S; Taudon N; Maynadier M; Tran Van Ba C; Margout D; Bordat Y; Fraisse L; Wengelnik K; Cerdan R; Bressolle-Gomeni F; Vial HJ
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28607017
[TBL] [Abstract][Full Text] [Related]
5. Effect of a bis-thiazolium compound on the biosynthesis of Plasmodium falciparum phospholipids.
Ahiboh H; Djaman AJ; Yapi FH; Edjeme-Aké A; Hauhouot-Attoungbré ML; Yayo ED; Monnet D
J Enzyme Inhib Med Chem; 2009 Aug; 24(4):911-7. PubMed ID: 19235542
[TBL] [Abstract][Full Text] [Related]
6. Potent antihematozoan activity of novel bisthiazolium drug T16: evidence for inhibition of phosphatidylcholine metabolism in erythrocytes infected with Babesia and Plasmodium spp.
Richier E; Biagini GA; Wein S; Boudou F; Bray PG; Ward SA; Precigout E; Calas M; Dubremetz JF; Vial HJ
Antimicrob Agents Chemother; 2006 Oct; 50(10):3381-8. PubMed ID: 17005821
[TBL] [Abstract][Full Text] [Related]
7. Unraveling the mode of action of the antimalarial choline analog G25 in Plasmodium falciparum and Saccharomyces cerevisiae.
Roggero R; Zufferey R; Minca M; Richier E; Calas M; Vial H; Ben Mamoun C
Antimicrob Agents Chemother; 2004 Aug; 48(8):2816-24. PubMed ID: 15273086
[TBL] [Abstract][Full Text] [Related]
8. Identification of Antimalarial Compounds That Require CLAG3 for Their Uptake by
Mira-Martínez S; Pickford AK; Rovira-Graells N; Guetens P; Tintó-Font E; Cortés A; Rosanas-Urgell A
Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30782998
[TBL] [Abstract][Full Text] [Related]
9. Heme binding contributes to antimalarial activity of bis-quaternary ammoniums.
Biagini GA; Richier E; Bray PG; Calas M; Vial H; Ward SA
Antimicrob Agents Chemother; 2003 Aug; 47(8):2584-9. PubMed ID: 12878523
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the choline carrier of Plasmodium falciparum: a route for the selective delivery of novel antimalarial drugs.
Biagini GA; Pasini EM; Hughes R; De Koning HP; Vial HJ; O'Neill PM; Ward SA; Bray PG
Blood; 2004 Nov; 104(10):3372-7. PubMed ID: 15205262
[TBL] [Abstract][Full Text] [Related]
11. A choline-releasing glycerophosphodiesterase essential for phosphatidylcholine biosynthesis and blood stage development in the malaria parasite.
Ramaprasad A; Burda PC; Calvani E; Sait AJ; Palma-Duran SA; Withers-Martinez C; Hackett F; Macrae J; Collinson L; Gilberger TW; Blackman MJ
Elife; 2022 Dec; 11():. PubMed ID: 36576255
[TBL] [Abstract][Full Text] [Related]
12. A systematic approach to understand the mechanism of action of the bisthiazolium compound T4 on the human malaria parasite, Plasmodium falciparum.
Le Roch KG; Johnson JR; Ahiboh H; Chung DW; Prudhomme J; Plouffe D; Henson K; Zhou Y; Witola W; Yates JR; Mamoun CB; Winzeler EA; Vial H
BMC Genomics; 2008 Oct; 9():513. PubMed ID: 18973684
[TBL] [Abstract][Full Text] [Related]
13. Exploring prodrug approaches for albitiazolium and its analogues.
Peyrottes S; Caldarelli S; Wein S; Perigaud C; Vial H
Curr Top Med Chem; 2014; 14(14):1653-67. PubMed ID: 25116583
[TBL] [Abstract][Full Text] [Related]
14. Infected erythrocyte choline carrier inhibitors: exploring some potentialities inside Plasmodium phospholipid metabolism for eventual resistance acquisition.
Vial HJ; Ancelin ML; Elabbadi N; Orcel H; Yeo HJ; Gumila C
Mem Inst Oswaldo Cruz; 1994; 89 Suppl 2():91-7. PubMed ID: 7565141
[TBL] [Abstract][Full Text] [Related]
15. A class of potent antimalarials and their specific accumulation in infected erythrocytes.
Wengelnik K; Vidal V; Ancelin ML; Cathiard AM; Morgat JL; Kocken CH; Calas M; Herrera S; Thomas AW; Vial HJ
Science; 2002 Feb; 295(5558):1311-4. PubMed ID: 11847346
[TBL] [Abstract][Full Text] [Related]
16. Disulfide prodrugs of albitiazolium (T3/SAR97276): synthesis and biological activities.
Caldarelli SA; Hamel M; Duckert JF; Ouattara M; Calas M; Maynadier M; Wein S; Périgaud C; Pellet A; Vial HJ; Peyrottes S
J Med Chem; 2012 May; 55(10):4619-28. PubMed ID: 22591034
[TBL] [Abstract][Full Text] [Related]
17. Enhanced choline and Rb+ transport in human erythrocytes infected with the malaria parasite Plasmodium falciparum.
Kirk K; Wong HY; Elford BC; Newbold CI; Ellory JC
Biochem J; 1991 Sep; 278 ( Pt 2)(Pt 2):521-5. PubMed ID: 1898345
[TBL] [Abstract][Full Text] [Related]
18. Regulation of phosphatidylcholine biosynthesis in Plasmodium-infected erythrocytes.
Ancelin ML; Vial HJ
Biochim Biophys Acta; 1989 Jan; 1001(1):82-9. PubMed ID: 2536284
[TBL] [Abstract][Full Text] [Related]
19. Uptake of purines in Plasmodium falciparum-infected human erythrocytes is mostly mediated by the human equilibrative nucleoside transporter and the human facilitative nucleobase transporter.
Quashie NB; Ranford-Cartwright LC; de Koning HP
Malar J; 2010 Jan; 9():36. PubMed ID: 20113503
[TBL] [Abstract][Full Text] [Related]
20. Antimalarial activity of 77 phospholipid polar head analogs: close correlation between inhibition of phospholipid metabolism and in vitro Plasmodium falciparum growth.
Ancelin ML; Calas M; Bompart J; Cordina G; Martin D; Ben Bari M; Jei T; Druilhe P; Vial HJ
Blood; 1998 Feb; 91(4):1426-37. PubMed ID: 9454774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
